Abbott Laboratories (ABT) Q4 2025 (USD): Adj. EPS 1.50 (exp. 1.50), Revenue 11.46bln (exp. 11.80bln)
Importance
Level 1
Guidance:
- Q1 adj. EPS 1.12-1.18 (exp. 1.20).
- FY adj. EPS 5.55-5.80 (exp. 5.68).
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#ABBOTT LABORATORIES#ABT.US#FOREX#EQUITIES#METALS#EU SESSION#US SESSION#HEALTH CARE EQUIPMENT#METALS & MINING#HEALTH CARE EQUIPMENT & SUPPLIES#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#S&P 500 INDEX#ABT#DXY#US EQUITIES